Recently, pre-treatment M2 macrophage infiltration was associated with poor response to chemotherapy and shorter DFS in ESCC patients [53,54], whereas the presence of FoxP3+ TILs was also related to a worse prognosis in ovarian cancer patients [58,60]. Here, FOXP3 is linked to ovarian cancer.